Antihypertensive drug prescribing in Grampian

British Journal of Clinical Pharmacology

Volumn 60, Issue 3, 2005, Pages 300-305

  Ross, Sarah ^a,b   Macleod, Mary Joan ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti hypertensives; Hypertension; Pharmacoepidemiology

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FELODIPINE; FOSINOPRIL; GENERIC DRUG; IMIDAPRIL; LABETALOL; LISINOPRIL; METHYLDOPA; MOEXIPRIL; NIFEDIPINE; PERINDOPRIL; QUINAPRIL; RAMIPRIL; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL;

ANTIHYPERTENSIVE THERAPY; CALCULATION; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; DRUG COST; DRUG FORMULARY; DRUG INDICATION; HEALTH CARE COST; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; UNITED KINGDOM;

ANTIHYPERTENSIVE AGENTS; COSTS AND COST ANALYSIS; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SCOTLAND;

EID: 24044481622     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02414.x     Document Type: Review

References (15)

1. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
2. National Institute for Clinical Excellence. Management of hypertension in adults in primary care. Available at: http:// www.nice.org.uk/pdf/ CG018fullguideline.pdf. Accessed August 27 2004.
3. Ramsay LE, Williams B, Johnston GD, MacGregor G, Poston L, Potter J, Poulter N, Russell G. Guidelines for management of hypertension. Report of the third Working Party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-92.
4. Williams B, Poulter NR, Brown MJ, Davies M, McInnes GT, Potter JP, Sever PS, Thom SMcG. Guidelines for management of hypertension: report of the fourth Working Party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004; 18: 139-85.
5. Ross S. Towards better blood pressure control. The effect of patients' and doctors' attitudes [Thesis]. Aberdeen: University of Aberdeen; 2004.
6. Cranney M, Barton S, Walley T. The management of hypertension in the elderly by general practitioners in Merseyside: the rule of halves revisited. Br J Gen Pract 1998; 48: 1146-50.
7. Morton-Jones TJ, Pringle MAL Prescribing costs in dispensing practices. Br Med J 1993; 306: 1244-6.
8. Baines DL, Tolley KH, Whynes DK. The costs of prescribing in dispensing practices. J Clin Pharm Ther 1996; 21: 343-8.
9. Coste J, Venot A. An epidemiological approach to drug prescribing quality assessment: a study in primary care practice in France. Med Care 1999; 37: 1294-307.
10. Nilsson G, Hjemdahl P, Hassler A, Vitols S, Wallen NH, Krakau I. Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners. Eur J Clin Pharmacol 2001; 56: 843-8.
11. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs, a study of a United Kingdom population. Br Med J 1995; 311: 293-5.
12. Prosser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs - the importance of who says what. Fam Pract 2003; 20: 61-8.
13. Sweeney KG, MacAuley D, Gray DP. Personal significance: the third dimension. Lancet 1998; 351: 134-6.
14. Grol R. Beliefs and evidence in changing clinical practice. Br Med J 1997; 315: 418-21.
15. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995; 153: 1423-31.